IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com

* Proteus®PLUS is the brand name of a Proteus®235 configuration

About Beijing Proton Medical Center
The Beijing Proton Medical Center is jointly-developed by Concord Medical Services and China-Japan Friendship Hospital. The 5,000 square meter, international-standards medical facility will be equipped with radiotherapy and diagnostic equipment including proton therapy system, linear accelerator, and PET-CT. It will also provide inpatient services to meet patients’ specific needs. Concord Medical is committed to providing patients with the most reliable and comprehensive cancer radiotherapy in China


About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2016, the Company operated a network of 123 centers with 73 hospital partners that spanned 52 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. As part of its high-end cancer hospital development strategy and oversea business extension, the Company acquired Concord Cancer Hospital, a private hospital in Singapore in April, 2015.

Back to HCB News

Rad Oncology Homepage